Hepatitis C in Clinically Discordant Hemophilic Siblings
NCT00007371 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-09-26
Summary
To define the natural history, immunologic, and genetic factors that influence the clinical outcome of hepatitis C in a cohort of hemophilic siblings.
Conditions
- Blood Disease
- Hemophilia A
- Hepatitis, Viral, Human
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Michael Fried · University of North Carolina
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-09-30
- Primary Completion
- 2004-08-31
- Completion
- 2004-08-31
More Related Trials
-
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997 ·Status: RECRUITING
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 ·Status: COMPLETED
-
Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
NCT00867243 ·Status: TERMINATED
-
Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells
NCT02545387 ·Status: WITHDRAWN
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
NCT00610597 ·Status: COMPLETED
-
Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis
NCT03693586 ·Status: COMPLETED
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With Chronic Hepatitis C
NCT01272479 ·Status: COMPLETED
-
Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease
NCT05865691 ·Status: RECRUITING
-
Immune Cell Dysfunction in Severe Alcoholic Hepatitis
NCT02275195 ·Status: RECRUITING
-
Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
NCT04800731 ·Status: COMPLETED
-
Alpha -1- Microglobulin (α1M) as an Early Biomarker in Renal Extrahepatic Manifestations of HCV-infection
NCT05276700 ·Status: UNKNOWN
-
Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02038387 ·Status: UNKNOWN ·Phase: NA
-
Hematological Disorders in Covid 19 Patients
NCT05182528 ·Status: UNKNOWN
-
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
NCT00606528 ·Status: COMPLETED
-
Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C
NCT01428700 ·Status: COMPLETED
-
Pathology of Hepatitis c Nephropathy
NCT03476031 ·Status: UNKNOWN
-
sgp130 in Chronic Human Liver Disease
NCT00770198 ·Status: COMPLETED
-
Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
NCT01200082 ·Status: TERMINATED
-
Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy
NCT03226717 ·Status: UNKNOWN
-
Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia
NCT00169871 ·Status: COMPLETED
-
Bartonella in Liver Transplant Patients
NCT02595710 ·Status: COMPLETED
-
Examining the Immune Response in Patients With Gaucher Disease and Hepatitis C
NCT01274208 ·Status: UNKNOWN